PortfoliosLab logoPortfoliosLab logo
SCWO vs. AMLX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SCWO vs. AMLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in 374Water Inc. Common Stock (SCWO) and Amylyx Pharmaceuticals, Inc. (AMLX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SCWO achieves a 4.41% return, which is significantly lower than AMLX's 34.77% return.


SCWO

1D
-5.33%
1M
-12.35%
YTD
4.41%
6M
-10.58%
1Y
-40.30%
3Y*
-57.16%
5Y*
-37.02%
10Y*
0.38%

AMLX

1D
3.89%
1M
19.88%
YTD
34.77%
6M
30.24%
1Y
222.38%
3Y*
-10.96%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SCWO vs. AMLX - Yearly Performance Comparison


2026 (YTD)2025202420232022
SCWO
374Water Inc. Common Stock
4.41%-70.11%-51.93%-50.35%-17.10%
AMLX
Amylyx Pharmaceuticals, Inc.
34.77%219.58%-74.32%-60.16%75.95%

Correlation

The correlation between SCWO and AMLX is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Jan 7, 2022

0.11

Fundamentals

EPS

SCWO:

$0.19

AMLX:

-$1.55

Total Revenue (TTM)

SCWO:

$215.04B

AMLX:

$0.00

Gross Profit (TTM)

SCWO:

-$2.35T

AMLX:

-$20.10M

EBITDA (TTM)

SCWO:

-$20.98T

AMLX:

-$150.30M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SCWO vs. AMLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SCWO
SCWO Risk / Return Rank: 3535
Overall Rank
SCWO Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
SCWO Sortino Ratio Rank: 4747
Sortino Ratio Rank
SCWO Omega Ratio Rank: 4646
Omega Ratio Rank
SCWO Calmar Ratio Rank: 2323
Calmar Ratio Rank
SCWO Martin Ratio Rank: 2828
Martin Ratio Rank

AMLX
AMLX Risk / Return Rank: 9494
Overall Rank
AMLX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AMLX Sortino Ratio Rank: 9595
Sortino Ratio Rank
AMLX Omega Ratio Rank: 9191
Omega Ratio Rank
AMLX Calmar Ratio Rank: 9696
Calmar Ratio Rank
AMLX Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SCWO vs. AMLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for 374Water Inc. Common Stock (SCWO) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SCWOAMLXDifference
Sharpe ratioReturn per unit of total volatility

-3.59

Sortino ratioReturn per unit of downside risk

-3.21

Omega ratioGain probability vs. loss probability

1.08

1.44

-0.36

Calmar ratioReturn relative to maximum drawdown

-0.54

7.31

-7.85

Martin ratioReturn relative to average drawdown

-0.76

15.68

-16.44

SCWO vs. AMLX - Sharpe Ratio Comparison

The current SCWO Sharpe Ratio is -0.26, which is lower than the AMLX Sharpe Ratio of 3.33. The chart below compares the historical Sharpe Ratios of SCWO and AMLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SCWO vs. AMLX - Drawdown Comparison

The maximum SCWO drawdown since its inception was -99.05%, roughly equal to the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for SCWO and AMLX.


Loading charts...

Drawdown Indicators


SCWOAMLXDifference

Max Drawdown

Largest peak-to-trough decline

-99.05%

-96.04%

-3.01%

Max Drawdown (1Y)

Largest decline over 1 year

-74.93%

-30.61%

-44.32%

Max Drawdown (3Y)

Largest decline over 3 years

-93.52%

-93.09%

-0.43%

Max Drawdown (5Y)

Largest decline over 5 years

-96.45%

Max Drawdown (10Y)

Largest decline over 10 years

-96.45%

Current Drawdown

Current decline from peak

-95.69%

-60.22%

-35.47%

Average Drawdown

Average peak-to-trough decline

-56.77%

-59.40%

+2.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

52.95%

14.25%

+38.70%

Volatility

SCWO vs. AMLX - Volatility Comparison

374Water Inc. Common Stock (SCWO) has a higher volatility of 29.56% compared to Amylyx Pharmaceuticals, Inc. (AMLX) at 16.44%. This indicates that SCWO's price experiences larger fluctuations and is considered to be riskier than AMLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SCWOAMLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.56%

16.44%

+13.12%

Volatility (6M)

Calculated over the trailing 6-month period

77.64%

43.21%

+34.43%

Volatility (1Y)

Calculated over the trailing 1-year period

157.71%

67.39%

+90.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

108.29%

91.47%

+16.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

188.73%

91.47%

+97.26%

Dividends

SCWO vs. AMLX - Dividend Comparison

Neither SCWO nor AMLX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SCWO vs. AMLX - Financials Comparison

This section allows you to compare key financial metrics between 374Water Inc. Common Stock and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00B200.00B20222023202420252026
215.03B
0
(SCWO) Total Revenue
(AMLX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SCWO and AMLX have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SCWO has higher volatility (29.56%) compared to AMLX (16.44%). In terms of maximum drawdown, SCWO dropped -99.05% vs AMLX's -96.04%.

AMLX currently has the higher Sharpe Ratio (3.33 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SCWO and AMLX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer